About 1 result found for searched term "Cemiplimab" (0.126 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M15101 | Cemiplimab | PD-1/PD-L1 |
| Libtayo; REGN-2810; cemiplimab-rwlc | ||
| Cemiplimab (Libtayo) is a human monoclonal antibody injected intravenously that targets programmed cell death-1 receptor (PD-1) and blocks its interaction with programmed death ligands PD-1 and PD-L2. Cemiplimab blocks T-cell inactivation and boosts the immune system's antitumor response. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
